REQUEST A DEMO
Total
USD $0.00
Search more companies

Novoderma Pharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Retail Trade
Full name: Novoderma Pharma S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Novoderma Pharma S.A. is based in Ecuador, with the head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 24, 2019. The total number of employees is currently 1 (2024). Its’ total assets recorded a negative growth of 35.7%.

Headquarters
Calle Ab Eloy Alfaro
Quito; Pichincha;

Contact Details: Purchase the Novoderma Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Novoderma Pharma S.A. report to view the information.
Registered Capital:
Purchase the Novoderma Pharma S.A. report to view the information.
Financial Auditors:
Purchase the Novoderma Pharma S.A. report to view the information.
Incorporation Date:
April 24, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Novoderma Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-35.7%
Total Equity
-30.26%
Return on Equity (ROE)
N/A
Quick Ratio
269.67%
Cash Ratio
10.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?